Fintel reports that on June 24, 2025, Guggenheim initiated coverage of Amylyx Pharmaceuticals (NasdaqGS:AMLX) with a Buy recommendation. Analyst Price Forecast Suggests 119.44% Upside As of June 20, ...

Inspector General of Police Deepak Thapa noted that the Kathmandu Valley is currently witnessing a surge in drug-related ...

Regeneron Pharmaceuticals, Inc. faces challenges with Eylea sales but sees growth from Dupixent and obesity drugs. Click for ...

Ion chromatography has gradually been adopted by pharmaceutical laboratories, but not without challenges. Read more here: ...

Fintel reports that on June 17, 2025, RBC Capital initiated coverage of EyePoint Pharmaceuticals (NasdaqGM:EYPT) with a ...

Madrigal Pharma's REZDIFFRA sees 33% Q1 2025 sales growth, strong EU progress, and promising MASH data. Read why I maintain ...

Do you want to learn a new sport or hobby, and you’re looking for lessons within a budget? The online platform Teach Me To is ...

Chemistry falls under the umbrella of natural sciences, alongside other fields like biology, geology and physics. Chemistry ...

Albert Shirakian, CEO of Retina Vitreous Associates Medical Group, joins the Armenian EyeCare Project's Board of Directors, ...

The global pharmaceutical lipids market is valued at USD 5.4 billion in 2025, registering Y-o-Y growth of 5.1% attaining market value of USD 9.0 billion by 2035. The revenue generated by allergy ...

Cycle Pharmaceuticals announced that the FDA has approved HARLIKU (nitisinone) Tablets for the reduction of urine homogentisic acid (HGA) in adult patients with AKU. 1 ...